Triple-Negative Breast Cancer: Intact Mismatch Repair and Partial Co-Expression of PD-L1 and LAG-3.

Front Immunol · 2021 · PMC7943629 · PMID 33717059

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

They suggested that this may be significant for evaluating ICI anti-tumor activity in relevant clinical trials via stratification of PD-L1 + and double-positive PD-L1 and LAG-3 ( 16 ).

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.